19.03.2015 07:51 Uhr in Kultur & Kunst von -
![GATC Biotech becomes first European services provider offering full access to QIAGENs Ingenuity® Variant Analysis](https://www.prmaximus.de/template/media/mod_article/article/122750_0.png)
740x491 Pixel - Dateigröße: 1422,13 Kb
(Mynewsdesk) * InViewTM Human Exome and QIAGEN’s software a perfect match
* Agreement provides comprehensive data analysis and interpretation to next generation sequencing customers of GATC Biotech
* Highest data quality paired with world-class bioinformatics analysis for exome sequencing experiments
Constance, Germany, March 19, 2015: GATC Biotech announced today the integration of QIAGEN’s Ingenuity® Variant AnalysisTM solution to complement their InViewTM Human Exome, providing ... ... weiter lesen Quelle
* Agreement provides comprehensive data analysis and interpretation to next generation sequencing customers of GATC Biotech
* Highest data quality paired with world-class bioinformatics analysis for exome sequencing experiments
Constance, Germany, March 19, 2015: GATC Biotech announced today the integration of QIAGEN’s Ingenuity® Variant AnalysisTM solution to complement their InViewTM Human Exome, providing ... ... weiter lesen Quelle
Pressefach abonnieren
via RSS-Feed abonnieren
via E-Mail abonnieren
Pressekontakt
Dr. Helge Schnerr
-
Jakob-Stadler-Platz 7
78467 Konstanz
-
Drucken
Weiterempfehlen
PDF
Schlagworte
Permanentlinks
https://www.prmaximus.de/122750-
Jakob-Stadler-Platz 7
78467 Konstanz
-
https://www.prmaximus.de/pressefach/-pressefach.html
Die Pressemeldung "GATC Biotech becomes first European services provider offering full access to QIAGENs Ingenuity® Variant Analysis" unterliegt dem Urheberrecht.
Jegliche Verwendung dieses Textes, auch auszugsweise, erfordert die vorherige schriftliche Erlaubnis des Autors.
Autor der Pressemeldung "GATC Biotech becomes first European services provider offering full access to QIAGENs Ingenuity® Variant Analysis" ist -, vertreten durch Dr. Helge Schnerr.